Evaluation of the Alcohol Elimination Effect of TCI711 Probiotic (Bacillus Coagulans) on Adult Individuals

TCI

Status: Completed

Conditions: Breath Alcohol Level

Treatments: Dietary Supplement: Bacillus coagulans TCI711

Study type: Interventional

Funder types: Industry

Identifiers

NCT04457661

20-036-A

Details and patient eligibility

About

Investigating the possibility of using Bacillus coagulans TCI711 to improve the efficiency of alcohol removal in adult individuals.

Enrollment: 19 patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers aged between 20 to 60.
• Systolic pressure below 140
• Score of C-CAGE Questionnaire below 8 (male)/6 (female)
• Prohibiting other supplements before 2 weeks of the study and during the study
• Prohibiting alcohol drinks before 24 hours of the study
• Prohibiting caffeine drinks before 12 hours of the study

Exclusion criteria

• Alcohol or drug allergy
• Liver, kidney, cardiovascular, or chronic diseases
• Other severe disorders
• Hypertension
• Pregnancy or lactation
• Already involved in clinical testing
• Other supplements

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

19 participants in 1 patient group

TCI711 probiotic

Experimental group

Description:

Taking one capsule (containing 10\^10 of Bacillus coagulans TCI711) daily for one month

Treatment:

Dietary Supplement: Bacillus coagulans TCI711